Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions.
Where this comes from
- Record sourced from PubMed, PMID 16498087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
On contrast-enhanced sonography, second-generation contrast media have shown a spleen-specific uptake of the microbubble contrast agent. To date, there is little data about the diagnostic value of contrast-enhanced sonography in perisplenic lesions. In patients with a perisplenic tumor of unknown cause, contrast-enhanced sonography enables the diagnosis or exclusion of accessory spleens.
Medical subject headings
- Contrast Media
- Phospholipids
- Splenic Diseases
- Sulfur Hexafluoride